Abstract
In this review we discuss epigenetic disorders that result from aberrations in genes linked to epigenetic regulation. We describe current testing methods for the detection of copy number variants (CNVs) in Mendelian disorders, dosage sensitivity, reciprocal phenotypes and the challenges of test selection and overlapping clinical features in genetic diagnosis. We discuss aberrations of DNA methylation and propose a role for episignatures as a novel clinical testing method in CNV disorders. Finally, we postulate that episignature mapping in CNV disorders may provide novel insights into the molecular mechanisms of disease and unlock key findings of the genome-wide impact on disease gene networks.
Original language | English |
---|---|
Pages (from-to) | 1373-1388 |
Number of pages | 16 |
Journal | Epigenomics |
Volume | 14 |
Issue number | 21 |
DOIs | |
Publication status | Published - 1 Nov 2022 |
Keywords
- CNV
- DNA methylation
- EpiSign™
- Mendelian disorders
- epigenetic machinery
- episignature